Immunovant Sciences GmbH
3 clinical trials · 3 recruiting · INDUSTRY
Trials by Immunovant Sciences GmbH
RECRUITINGPhase 2NCT06980805
A Study to Assess the Safety, Tolerability, and Efficacy of IMVT-1402 in Participants With Cutaneous Lupus...
The primary purpose of this study is to evaluate the efficacy, safety, and tolerability of IMVT-1402 in participants with Cutaneous Lupus Erythematosus. The study will consist of...
Sponsor: Immunovant Sciences GmbHEnrolling: 5620 locations
Subacute Cutaneous Lupus ErythematosusChronic Cutaneous Lupus Erythematosus
RECRUITINGPhase 3NCT07039916
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
The purpose of the study is to assess the efficacy, safety and tolerability of IMVT-1402 in adult participants with mild to severe generalized myasthenia gravis.
Sponsor: Immunovant Sciences GmbHEnrolling: 23120 locations
Generalized Myasthenia Gravis
RECRUITINGPhase 2NCT07018323
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves'...
This is a multi-center, global, randomized, double-blind, placebo-controlled Phase 2b study to assess the efficacy, safety, and tolerability of IMVT-1402 in adult participants...
Sponsor: Immunovant Sciences GmbHEnrolling: 21020 locations
Graves' Disease